IN2012DN00227A - - Google Patents
Info
- Publication number
- IN2012DN00227A IN2012DN00227A IN227DEN2012A IN2012DN00227A IN 2012DN00227 A IN2012DN00227 A IN 2012DN00227A IN 227DEN2012 A IN227DEN2012 A IN 227DEN2012A IN 2012DN00227 A IN2012DN00227 A IN 2012DN00227A
- Authority
- IN
- India
- Prior art keywords
- cefquinome
- particles
- acid
- addition salt
- sulfate
- Prior art date
Links
- 239000002245 particle Substances 0.000 abstract 6
- 239000002253 acid Substances 0.000 abstract 5
- YWKJNRNSJKEFMK-PQFQYKRASA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(5,6,7,8-tetrahydroquinolin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound N([C@@H]1C(N2C(=C(C[N+]=3C=4CCCCC=4C=CC=3)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 YWKJNRNSJKEFMK-PQFQYKRASA-N 0.000 abstract 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 4
- 229950009592 cefquinome Drugs 0.000 abstract 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- KYOHRXSGUROPGY-OFNLCGNNSA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(5,6,7,8-tetrahydroquinolin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrogen sulfate Chemical compound OS(O)(=O)=O.N([C@@H]1C(N2C(=C(C[N+]=3C=4CCCCC=4C=CC=3)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 KYOHRXSGUROPGY-OFNLCGNNSA-N 0.000 abstract 2
- 229960003237 betaine Drugs 0.000 abstract 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000004062 sedimentation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09165895 | 2009-07-20 | ||
| US22719509P | 2009-07-21 | 2009-07-21 | |
| PCT/EP2010/060376 WO2011009827A1 (en) | 2009-07-20 | 2010-07-19 | Method of making cefquinome particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00227A true IN2012DN00227A (pl) | 2015-05-01 |
Family
ID=41217555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN227DEN2012 IN2012DN00227A (pl) | 2009-07-20 | 2010-07-19 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120122832A1 (pl) |
| EP (1) | EP2456775B1 (pl) |
| JP (2) | JP5859436B2 (pl) |
| CN (1) | CN102471350B (pl) |
| AR (1) | AR077320A1 (pl) |
| AU (1) | AU2010275302B2 (pl) |
| BR (1) | BR112012001233B1 (pl) |
| CA (1) | CA2768088A1 (pl) |
| ES (1) | ES2432240T3 (pl) |
| IN (1) | IN2012DN00227A (pl) |
| MX (1) | MX2012000893A (pl) |
| PL (1) | PL2456775T3 (pl) |
| SG (1) | SG177728A1 (pl) |
| TW (1) | TWI400243B (pl) |
| WO (1) | WO2011009827A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR077320A1 (es) * | 2009-07-20 | 2011-08-17 | Intervet Int Bv | Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden. |
| CN114869850B (zh) * | 2022-06-20 | 2023-04-28 | 山东晟阳生物工程有限公司 | 硫酸头孢喹肟注射液 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
| US4791196A (en) * | 1986-09-26 | 1988-12-13 | Sankyo Company Limited | Crystalline cephem carboxylic acid addition salt |
| DE3706020A1 (de) | 1987-02-25 | 1988-09-08 | Hoechst Ag | Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung |
| DE4440141A1 (de) * | 1994-11-10 | 1996-05-15 | Hoechst Ag | Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung |
| CZ301938B6 (cs) | 1999-09-03 | 2010-08-04 | Janssen Pharmaceutica N. V. | Veterinární preparát pro podávání ve vode nerozpustných léku cílovému zvíreti prostrednictvím napájecího systému |
| WO2003063877A1 (en) * | 2002-02-01 | 2003-08-07 | Akzo Nobel N.V. | Cefquinome composition for intra-mammary administration in cattle |
| ES2265590T3 (es) * | 2002-10-25 | 2007-02-16 | Intervet International Bv | Composicion farmaceutica de liberacion prolongada. |
| US6911441B2 (en) * | 2002-12-16 | 2005-06-28 | Akzo Nobel N.V. | Prolonged release pharmaceutical composition |
| ITMI20042139A1 (it) * | 2004-11-08 | 2005-02-08 | Acs Dobfar Spa | Procedimento per la produzione di cefepime e cefaposporine analoghe |
| JP5322649B2 (ja) * | 2005-10-29 | 2013-10-23 | インターベツト・インターナシヨナル・ベー・ベー | セフキノム組成物およびその使用方法 |
| CN101050220A (zh) * | 2007-05-21 | 2007-10-10 | 蒋春茂 | 一种动物抗生素硫酸头孢喹肟的制备方法 |
| CN101536985A (zh) * | 2008-03-17 | 2009-09-23 | 天津瑞普生物技术集团有限公司 | 一种畜禽使用的头孢喹肟肺靶向微球及其制备方法 |
| AR077320A1 (es) * | 2009-07-20 | 2011-08-17 | Intervet Int Bv | Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden. |
-
2010
- 2010-07-16 AR ARP100102611A patent/AR077320A1/es not_active Application Discontinuation
- 2010-07-16 TW TW099123476A patent/TWI400243B/zh not_active IP Right Cessation
- 2010-07-19 PL PL10734121T patent/PL2456775T3/pl unknown
- 2010-07-19 MX MX2012000893A patent/MX2012000893A/es active IP Right Grant
- 2010-07-19 BR BR112012001233-9A patent/BR112012001233B1/pt active IP Right Grant
- 2010-07-19 AU AU2010275302A patent/AU2010275302B2/en active Active
- 2010-07-19 CA CA2768088A patent/CA2768088A1/en not_active Abandoned
- 2010-07-19 WO PCT/EP2010/060376 patent/WO2011009827A1/en not_active Ceased
- 2010-07-19 SG SG2012004644A patent/SG177728A1/en unknown
- 2010-07-19 US US13/384,606 patent/US20120122832A1/en not_active Abandoned
- 2010-07-19 CN CN201080032586.XA patent/CN102471350B/zh active Active
- 2010-07-19 IN IN227DEN2012 patent/IN2012DN00227A/en unknown
- 2010-07-19 JP JP2012521010A patent/JP5859436B2/ja active Active
- 2010-07-19 EP EP10734121.6A patent/EP2456775B1/en active Active
- 2010-07-19 ES ES10734121T patent/ES2432240T3/es active Active
-
2015
- 2015-10-09 JP JP2015200919A patent/JP6346144B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AR077320A1 (es) | 2011-08-17 |
| CN102471350B (zh) | 2015-05-06 |
| CN102471350A (zh) | 2012-05-23 |
| WO2011009827A1 (en) | 2011-01-27 |
| TWI400243B (zh) | 2013-07-01 |
| SG177728A1 (en) | 2012-02-28 |
| CA2768088A1 (en) | 2011-01-27 |
| EP2456775A1 (en) | 2012-05-30 |
| BR112012001233B1 (pt) | 2019-06-11 |
| TW201116538A (en) | 2011-05-16 |
| BR112012001233A2 (pt) | 2016-03-08 |
| AU2010275302B2 (en) | 2014-10-09 |
| MX2012000893A (es) | 2012-02-28 |
| ES2432240T3 (es) | 2013-12-02 |
| JP2016047827A (ja) | 2016-04-07 |
| PL2456775T3 (pl) | 2014-01-31 |
| JP5859436B2 (ja) | 2016-02-10 |
| US20120122832A1 (en) | 2012-05-17 |
| EP2456775B1 (en) | 2013-08-21 |
| JP2012533596A (ja) | 2012-12-27 |
| AU2010275302A1 (en) | 2012-02-02 |
| JP6346144B2 (ja) | 2018-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3218B1 (ar) | إنتاج كربونات كالسيوم مترسبة عالية النقاوة | |
| WO2012013454A8 (de) | Verfahren zur verminderung von magnetischen und/oder oxidischen verunreinigungen in lithium-metall-sauerstoff-verbindungen | |
| MX346652B (es) | Carbonato de calcio precipitado de desecho de la molienda de pulpa que tiene brillo mejorado y metodo para su produccion y uso. | |
| PE20141639A1 (es) | Proceso para preparar fumarato de dimetilo de alta pureza y cristalino | |
| MX2012010441A (es) | Microcapsulas mejoradas y la produccion de estas. | |
| EP4023641A3 (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
| IL229664A (en) | Method for producing phosphoric acid of the dihydrate/hemihydrate type | |
| EP2431374A4 (en) | PROCESS FOR PREPARING FINE PHOSPHONIC ACID METAL SALT PARTICLES | |
| MX340125B (es) | 2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento. | |
| TN2015000372A1 (en) | A method for concentrating rare-earth metals in phosphogypsum | |
| MY162811A (en) | Food containing milk ceramide, and process for production thereof | |
| WO2016016766A3 (en) | A process for the preparation of isavuconazonium or its salt thereof | |
| JP2014523491A5 (pl) | ||
| MY185172A (en) | Gypsum-based building products and method for the manufacture thereof | |
| BR112013030973A8 (pt) | processo para a preparação de amidas de prostaglandina | |
| WO2013185153A3 (en) | Process for the production of crystalline titanium powder | |
| MX2012013610A (es) | Complejo obtenido a partir de mezclas de acido hialuronico o una sal del mismo y sulfato de condroitina. | |
| IN2012DN00227A (pl) | ||
| CA2797442A1 (en) | Process for the production of ferrous sulphate monohydrate | |
| WO2015044853A3 (en) | Process for preparation of dimethyl fumarate | |
| UA103913C2 (uk) | Мікроелементна добавка до кормових сумішей для тварин і птахів в біодоступній формі | |
| WO2009037901A1 (ja) | 粉体化粧料およびこれに用いる平板状硫酸カルシウム２水塩の製造方法 | |
| MD20120130A2 (en) | Delta crystalline form of the L-arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it | |
| WO2011107843A3 (en) | Process for the preparation of atazanavir sulfate substantially free of diastereomers | |
| AR068520A1 (es) | Proceso para la produccion de sulfato de sodio e hidroxido de magnesio |